SKIA

What SKIA does

SKIA Inc. is a South Korea-based medical device company founded in 2018 that develops augmented reality (AR) surgical navigation platforms combining computer vision, AI-based medical imaging analysis, and markerless registration technology. The company's core SKIA Processor reconstructs CT and MRI DICOM data into 3D anatomical mesh models that are projected directly onto patients during surgery, eliminating the need for physical skin markers. Its product portfolio spans multiple surgical specialties: SKIA Body (general surgery, KMFDS-approved), SKIA OPD (AR patient education, available in Korea and India), SKIA Face (facial reconstruction, KMFDS-approved May 2024), SKIA HEAD (FDA 510(k)-cleared May 2026 for US entry), SKIA Neuro and SKIA Breast (in confirmatory clinical trials), SKIA Forensics (AI-assisted autopsy), and development-stage ARUS (AR+ultrasound) and AREM (AR+AI+EM neuronavigation) modules. The platform achieves sub-2mm navigation accuracy meeting FDA stereotactic standards, with claimed 5-second markerless patient registration.

SKIA generates revenue primarily through one-time license sales of AR surgical navigation systems and software to enterprise hospital customers under quote-based annual pricing models, with a subscription/recurring component for SKIA OPD patient education and bespoke professional services for 3D anatomical modeling. Its go-to-market combines direct enterprise sales to hospital systems in South Korea (Asan Medical Center, Ewha Womans University Hospital, Yonsei Severance, SNU Hospital) with a jointly-controlled SKIA India LLP joint venture for the Indian market (KIMS, GSL, Rainbow Children's, AIG hospitals) and a strategic channel partnership with Structure Sensors for US distribution. The company has secured approximately $10 million USD across Series A, bridge, and grant funding, with marquee recognitions including CES 2024 Innovation Award, Medtech Innovator Top 20, Red Dot Design Award, and Johnson & Johnson Quickfire Challenge, and has supported 1000+ surgeries globally with a 97% reported patient satisfaction rate.

Name

SKIA

Legal name

SKIA Inc.

Website

https://skia.kr

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

SKIA is a South Korea-based medical device company founded in 2018 that provides markerless augmented reality surgical navigation systems powered by AI-based CT/MRI image reconstruction, serving hospital systems across neurosurgery, breast oncology, general surgery, and patient education in Korea, India, and the US.

Ownership category

akta.pro rank

Product category

Surgical Navigation Systems

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD), Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)

Keywords

• AR surgical navigation
• Augmented reality surgery
• Medical imaging AI
• Surgical guidance systems
• Markerless patient registration

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. AR Surgical Navigation Systems: Sale of AR-based surgical navigation systems to hospitals and surgical centers. SKIA sells its tablet-based AR devices combined with software licenses for surgical guidance applications.
2. SKIA OPD (Patient Education): AR-based patient education solution sold to hospitals for outpatient consultation. Currently available for sale in South Korea and India.
3. 3D Modeling Services: Bespoke 3D modeling services where SKIA provides detailed 3D mapping of anatomical structures using AI-based auto-segmentation.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

SKIA develops and sells a markerless augmented reality (AR) and AI-powered surgical navigation platform that reconstructs patient CT/MRI imaging data into 3D anatomical models and projects them directly onto patients during surgery. The company offers specialty-specific solutions for neurosurgery, breast cancer surgery, general surgery, head/neck and facial reconstruction, outpatient patient education, and forensic autopsy, sold as enterprise software/hardware bundles to hospitals and surgical centers.

Product overview

SKIA offers a modular AR×AI surgical platform consisting of multiple specialized solutions. The core SKIA Processor platform reconstructs CT/MRI DICOM data into 3D anatomical models that are projected onto patients using markerless AR technology. SKIA Body (KMFDS-approved, available) and SKIA OPD (KMFDS-approved, available) provide general surgery navigation and patient education respectively. SKIA HEAD (FDA 510(k)-cleared) and SKIA Face (KMFDS-approved) serve head/neck and facial reconstruction surgeries. SKIA Breast (confirmatory trials) targets breast cancer surgery. Development-stage products include SKIA Forensics (AI-assisted autopsy), ARUS Navigation (AR+ultrasound), and AREM Navigation (AR+AI+EM). All solutions share the common technology foundation of markerless AR registration and AI-based anatomical recognition with sub-2mm accuracy.

Differentiator

Problem solved

Functional benefit

Brands

• SKIA Neuro: Surgical AR Navigation for Neurosurgery - Mobile AR neuronavigation solution with 1.5mm accuracy for brain and vascular mapping.
• SKIA Breast
• SKIA Body
• SKIA OPD
• SKIA Forensics
• ARUS Navigation
• AREM Navigation

Products and services

• SKIA Body General surgery AR navigation system that provides detailed 3D modeling of vital organs and blood vessels and projects patient-specific anatomical structures directly onto the body during surgery for real-time visualization. KMFDS-approved and available for sale in South Korea, targeted at general surgeons performing abdominal and hernia procedures.
• SKIA OPD AR-based patient education and consultation solution that reconstructs medical images into 3D and projects them onto patients to improve understanding of pathological conditions, surgical procedures, and recovery progress. Includes custom prescription printing features. Sold on a recurring subscription to hospital outpatient departments in South Korea and India.
• SKIA Neuro Surgical AR navigation system for neurosurgery providing ultra-precise brain and vascular mapping with 1.5mm accuracy. Uses AI-based auto-segmentation to create detailed 3D mapping of intracranial blood vessels. Targeted at neurosurgeons performing brain tumor resections and craniotomies; under development and not yet commercially available.
• SKIA Breast Breast cancer surgery AR navigation system with 1.7mm accuracy for soft tissue navigation. Enables real-time AR visualization for improved cancer detection and treatment planning without traditional wire markers. Targeted at breast cancer surgeons; under confirmatory clinical trials and not yet commercially available.
• SKIA HEAD FDA-cleared tablet-based AR surgical guidance system that projects 3D anatomical reconstructions onto patients during surgery. Enables real-time visualization and alignment without bulky operating-room equipment, powered by Structure Sensors. Targeted at US hospital surgical departments for head and neck procedures.
• SKIA Face Facial fracture reconstruction AR solution providing 3D simulation for creating symmetrical structures and modeling artificial bone implants, with AR previews of postoperative outcomes. Approved by Korean FDA (KMFDS) in May 2024 and targeted at plastic and reconstructive surgeons.
• SKIA Forensics AI-assisted autopsy solution trained on thousands of post-mortem CT datasets from Korean CSI. Identifies fractures, bleeding, and other signs of anomaly, providing realistic volume renderings and AR projection for forensic investigation. Targeted at crime scene investigators and medical examiners; under development.
• 3D Modeling Services

Quantifiable outcome

• Navigation accuracy of 1.5mm meeting FDA stereotactic standards (1.4mm in head/neck, 1.7mm in upper body)
• +4 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Structure SensorscoreTechnology or Integration · 29 May 2026Strategic hardware partnership for US market entry. Structure Sensors provides high-precision 3D sensors powering SKIA HEAD's AR surgical guidance system. Partnership enables FDA-cleared tablet-based AR navigation system commercial launch in United States.
• KIMS Hospital (Hyderabad)coreStrategic or Co-development PartnerClinical partnership where Dr. Manas Panigrahi's neurosurgery team performed 16+ brain surgeries using SKIA technology. Hospital serves as key clinical validation site and India market reference customer.
• Asan Medical CentercoreStrategic or Co-development PartnerMOU partnership for AR-based facial reconstruction surgery guide development since 2021. Research-centered hospital collaboration for plastic surgery applications.
• Ewha Womans University HospitalcoreStrategic or Co-development PartnerBio Core Facility collaboration. SKIA Breast confirmatory clinical trial partner along with SNU Hospital and Yonsei Severance Hospital. Also collaborating on abdominal fat measurement project for breast reconstruction.
• Korean CSIminorStrategic or Co-development PartnerSKIA Forensics trained on thousands of post-mortem CT datasets provided by Korean Crime Scene Investigation bureau for AI-assisted autopsy applications.
• GSL Hospital (India)minorChannel Partner/ Reseller/ DistributorTerm sheet signed for SKIA OPD patient education solution supply. 150+ doctors attended initial conference showcasing the technology.
• Rainbow Children's Hospital (India)minorChannel Partner/ Reseller/ DistributorTerm sheet signed for SKIA OPD deployment in pediatric hospital setting.
• AIG Hospital (India)minorChannel Partner/ Reseller/ DistributorTerm sheet signed for SKIA OPD patient education solution implementation.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Stryker (Navigation / Mako): Offers broad surgical navigation and robotics across orthopedics, spine, ENT, and neurosurgery. Comparable as a portfolio incumbent that could bundle or compete with SKIA's specialty navigation modules.
• Brainlab: Established global leader in surgical navigation, planning, and AR/3D visualization across neurosurgery, spine, ENT, and trauma. Directly comparable as a broad surgical-navigation incumbent against which SKIA's markerless AR platform competes.
• Medtronic (StealthStation): StealthStation is the dominant neuronavigation platform with deep hospital penetration. Represents the incumbent benchmark SKIA must displace on accuracy, workflow, and cost in neurosurgery.

Emerging players

• FundamentalVR: VR/haptic surgical simulation and training platform with AR extensions. Comparable as an emerging AR/VR surgery peer with overlapping clinical training and visualization use cases.
• Activ Surgical: AI- and AR-driven intraoperative visualization for minimally invasive surgery. Comparable as an emerging surgical visualization peer pursuing AI-enhanced surgical guidance.

Direct peers

• Augmedics: Developer of the xvision AR surgical navigation headset for spine surgery. Closest direct competitor to SKIA in markerless/headset-based AR surgical navigation and a relevant peer for US commercial benchmarks.
• Surgical Theater: Provides VR/AR surgical planning and 360-degree visualization for neurosurgery and other specialties. Comparable to SKIA's Neuro and Breast modules in converting imaging into immersive surgical visualization.
• Centerline Biomedical: Develops AR-based surgical navigation with deformable registration for vascular and endovascular procedures. Comparable as a peer in novel AR registration approaches for surgery.
• ImmersiveTouch: Provides immersive VR/AR surgical planning and simulation platforms for neurosurgery and other specialties. Comparable to SKIA's pre-operative planning and 3D visualization workflow.
• Elucent Medical: Develops AR-based surgical navigation systems, including for breast and soft-tissue tumor localization. Comparable to SKIA Breast in targeting wire-free, AR-guided tumor excision.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@skia5762
• LinkedInlinkedin.com/company/skia-ar

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SKIA